Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test

NCT01574677 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT01574677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01574677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2012
Completion date
Not reported
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer